Premier Alternatives

Adipo Therapeutics

Indianapolis, IN · Founded 2016 · Privately Held (backing)

Developer of polymer-based nanoparticles designed to transform the treatment of obesity-related diseases. Adipo Therapeutics is based in Indianapolis, IN and was founded in 2016. It was valued at $27 million at its later-stage round in Feb 2026, the last priced event on record. It has raised $14.8 million across 2 recorded rounds; the latest was a $4.7 million seed round in Nov 2024.

PMV mark · valuation
$27.0M
Oct 2026
Priced at
its later-stage round
Feb 2026
Total raised
$14.8M
Last round
Seed Round
Nov 2024

Adipo Therapeutics key facts

as of Oct 2026
  • Developer of polymer-based nanoparticles designed to transform the treatment of obesity-related diseases.
  • Adipo Therapeutics is valued at approximately $27.0M as of Oct 2026, set at its later-stage round, Feb 2026; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $14.8M across 2 recorded rounds; the latest was Seed Round ($4.7M) in Nov 2024.
  • Notable investors include Elevate Ventures, AJI Capital, David Campbell, IU Ventures, John Lechleiter — 13 tracked in total.
  • Adipo Therapeutics has filed 2 Form Ds with the SEC since 2020, most recently Dec 2024 ($4.7M sold to 20 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$27.0M

Valued at $27.0M at its later-stage round, Feb 2026. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Adipo Therapeutics with a free account
  • ·The complete investor list: 13 names
  • ·Watch Adipo Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Adipo Therapeutics funding rounds

2 rounds
Nov 2024Seed Round$4.7MSEC filing▮
Aug 2020Seed Round$1.3MSEC filing▮
Full funding history →

Adipo Therapeutics valuation

Adipo Therapeutics was valued at $27 million at its later-stage round in Feb 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Adipo Therapeutics raised?

Adipo Therapeutics has raised $14.8 million in total; 2 of its rounds are on record. The largest on record was a $4.7 million seed round in Nov 2024.

Adipo Therapeutics has filed 2 Form Ds with the SEC since 2020, most recently in Dec 2024 ($4.7 million sold to 20 investors).

Adipo Therapeutics investors

13 investors are on record for Adipo Therapeutics, including Elevate Ventures, AJI Capital, David Campbell and IU Ventures. The seed round in Nov 2024 drew 20 investors.

About Adipo Therapeutics

Developer of polymer-based nanoparticles designed to transform the treatment of obesity-related diseases. The company's notch-inhibiting nanoparticles are weekly, self-injected directly into subcutaneous white adipose tissue to convert energy-storing white fat into energy-burning brown fat, leading to systemic metabolic changes including increased energy expenditure, decreased body weight, improved insulin sensitivity, and improved fat storage, enabling patients to lose body weight naturally and restoring metabolic balance for people living with diabetes.

Sector
Healthcare
HQ
Indianapolis, IN, United States
Founded
2016
Employees
9
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.